Application of nitric oxide measurements in clinical conditions beyond asthma

Andrei Malinovschi*, Dora Ludviksdottir, Ellen Tufvesson, Giovanni Rolla, Leif Bjermer, Kjell Alving, Zuzana Diamant

*Bijbehorende auteur voor dit werk

    Onderzoeksoutput: Review articleAcademicpeer review

    213 Downloads (Pure)


    Fractional exhaled nitric oxide (FeNO) is a convenient, non-invasive method for the assessment of active, mainly Th2-driven, airway inflammation, which is sensitive to treatment with standard anti-inflammatory therapy. Consequently, FeNO serves as a valued tool to aid diagnosis and monitoring in several asthma phenotypes. More recently, FeNO has been evaluated in several other respiratory, infectious, and/or immunological conditions. In this short review, we provide an overview of several clinical studies and discuss the status of potential applications of NO measurements in clinical conditions beyond asthma.

    Originele taal-2English
    Aantal pagina's10
    TijdschriftEuropean clinical respiratory journal
    Nummer van het tijdschrift1
    StatusPublished - 2015

    Citeer dit